[go: up one dir, main page]

MA46728A - Polythérapie avec un inhibiteur de phosphoinositide 3-kinase avec une fraction de liaison au zinc - Google Patents

Polythérapie avec un inhibiteur de phosphoinositide 3-kinase avec une fraction de liaison au zinc

Info

Publication number
MA46728A
MA46728A MA046728A MA46728A MA46728A MA 46728 A MA46728 A MA 46728A MA 046728 A MA046728 A MA 046728A MA 46728 A MA46728 A MA 46728A MA 46728 A MA46728 A MA 46728A
Authority
MA
Morocco
Prior art keywords
polytherapy
phosphoinositide
kinase inhibitor
zinc binding
binding fraction
Prior art date
Application number
MA046728A
Other languages
English (en)
Inventor
Ali Fattaey
Garrett W Rhyasen
Original Assignee
Curis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curis Inc filed Critical Curis Inc
Publication of MA46728A publication Critical patent/MA46728A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
MA046728A 2016-11-02 2017-11-01 Polythérapie avec un inhibiteur de phosphoinositide 3-kinase avec une fraction de liaison au zinc MA46728A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662416329P 2016-11-02 2016-11-02

Publications (1)

Publication Number Publication Date
MA46728A true MA46728A (fr) 2019-09-11

Family

ID=62076339

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046728A MA46728A (fr) 2016-11-02 2017-11-01 Polythérapie avec un inhibiteur de phosphoinositide 3-kinase avec une fraction de liaison au zinc

Country Status (15)

Country Link
US (1) US20180133223A1 (fr)
EP (1) EP3535272A4 (fr)
JP (1) JP2020500175A (fr)
KR (1) KR20190077040A (fr)
CN (1) CN109923117A (fr)
AU (2) AU2017355385A1 (fr)
BR (1) BR112019008698A2 (fr)
CA (1) CA3040727A1 (fr)
EA (1) EA201991069A1 (fr)
IL (1) IL266135A (fr)
MA (1) MA46728A (fr)
MX (1) MX2019004842A (fr)
PH (1) PH12019500858A1 (fr)
SG (1) SG11201903723RA (fr)
WO (1) WO2018085342A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2733128T3 (es) 2011-04-01 2019-11-27 Curis Inc Inhibidor de fosfoinosítido 3-quinasa con un resto de unión a cinc
WO2020055840A1 (fr) * 2018-09-11 2020-03-19 Curis Inc. Polythérapie avec un inhibiteur de phosphoinositide 3-kinase ayant une fraction de liaison au zinc
CN112778212B (zh) * 2021-01-28 2022-03-15 苏州莱克施德药业有限公司 库潘尼西中间体2-胺基嘧啶-5-羧酸甲酯的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100152188A1 (en) * 2005-08-05 2010-06-17 Akella Satya Surya Visweswara Srinivas Novel Heterocyclic Compounds
CL2007003520A1 (es) * 2006-12-07 2008-08-22 Piramed Ltd Genentech Inc Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso para el tratamiento profilactico o terapeutico del cancer.
EA024252B1 (ru) * 2009-01-08 2016-08-31 Кьюрис, Инк. Ингибиторы фосфоинозитид-3-киназ с цинксвязывающей группой
ES2733128T3 (es) * 2011-04-01 2019-11-27 Curis Inc Inhibidor de fosfoinosítido 3-quinasa con un resto de unión a cinc
US20130102595A1 (en) * 2011-04-15 2013-04-25 Curis, Inc. Treatment of cancers having k-ras mutations
UY34632A (es) * 2012-02-24 2013-05-31 Novartis Ag Compuestos de oxazolidin- 2- ona y usos de los mismos
CN104718212B (zh) * 2012-10-10 2017-06-16 霍夫曼-拉罗奇有限公司 制备噻吩并嘧啶化合物的方法
US10111897B2 (en) * 2013-10-03 2018-10-30 Duke University Compositions and methods for treating cancer with JAK2 activity
WO2015160975A2 (fr) * 2014-04-16 2015-10-22 Infinity Pharmaceuticals, Inc. Polythérapies

Also Published As

Publication number Publication date
PH12019500858A1 (en) 2019-12-02
JP2020500175A (ja) 2020-01-09
CN109923117A (zh) 2019-06-21
BR112019008698A2 (pt) 2019-07-16
EP3535272A1 (fr) 2019-09-11
WO2018085342A1 (fr) 2018-05-11
MX2019004842A (es) 2019-06-20
US20180133223A1 (en) 2018-05-17
AU2017355385A1 (en) 2019-05-30
EA201991069A1 (ru) 2019-10-31
AU2020227036A1 (en) 2020-09-17
SG11201903723RA (en) 2019-05-30
EP3535272A4 (fr) 2020-06-17
KR20190077040A (ko) 2019-07-02
IL266135A (en) 2019-06-30
CA3040727A1 (fr) 2018-05-11

Similar Documents

Publication Publication Date Title
IL270226A (en) A heater assembly for an aerosol-generating device
MA52090A (fr) Polythérapie
DK3376857T3 (da) Ikke-humane dyr, der har et humaniseret lymfocyt-aktiveringsgen 3
FR3020160B1 (fr) Systeme d'execution de code avec mecanisme d'hypervision en aveugle
MA47676A (fr) Polythérapie
JP1640204S (ja) フェンダー
EP3467606A4 (fr) Véhicule de travail autonome
EP3515414A4 (fr) Polythérapie
EP3374591A4 (fr) Un dispositif de raccordement
PT3362477T (pt) Proteínas de ligação a antigénio que ativam o recetor de leptina
EP3377237A4 (fr) Dégorgeoir
EP3387194A4 (fr) Dégorgeoir
LT3337477T (lt) Kompozicijos, apimančios fosfoinozitido 3-kinazės inhibitorius ir antrąjį antiproliferacinį agentą
ME03325B (fr) Inhibiteur de kinase aurora a
MA49921A (fr) Polythérapie
EP3560625A4 (fr) Outil de fixation
EP3709783A4 (fr) Chaîne de montage de composants
EP3988148C0 (fr) Zählvorrichtung mit aussperrmechanismus
EP3370773A4 (fr) Polythérapie constituées d'immunotoxines et d'un inhibiteur de point de contrôle
EP3595438A4 (fr) Chaussure pour chevaux
ME03677B (fr) Polythérapie
EP3532941A4 (fr) Codeur automatique de législation selon une logique
FR3046841B1 (fr) Couplemetre a torsion
MA46728A (fr) Polythérapie avec un inhibiteur de phosphoinositide 3-kinase avec une fraction de liaison au zinc
ITUB20160685A1 (it) Sella per un veicolo